229 related articles for article (PubMed ID: 24705154)
1. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
2. Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques.
Zhang Q; Liu J; Ao N; Yu H; Peng Y; Ou L; Zhang S
Sci Rep; 2020 Jan; 10(1):1220. PubMed ID: 31988348
[TBL] [Abstract][Full Text] [Related]
3. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
4. Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy.
Fogliata A; De Rose F; Franceschini D; Stravato A; Seppälä J; Scorsetti M; Cozzi L
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):785-793. PubMed ID: 29249528
[TBL] [Abstract][Full Text] [Related]
5. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
6. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer.
Abo-Madyan Y; Aziz MH; Aly MM; Schneider F; Sperk E; Clausen S; Giordano FA; Herskind C; Steil V; Wenz F; Glatting G
Radiother Oncol; 2014 Mar; 110(3):471-6. PubMed ID: 24444525
[TBL] [Abstract][Full Text] [Related]
7. Accelerated partial breast irradiation (APBI): are breath-hold and volumetric radiation therapy techniques useful?
Essers M; Osman SO; Hol S; Donkers T; Poortmans PM
Acta Oncol; 2014 Jun; 53(6):788-94. PubMed ID: 24689645
[TBL] [Abstract][Full Text] [Related]
8. Secondary cancer risk after whole-breast radiation therapy: field-in-field versus intensity modulated radiation therapy versus volumetric modulated arc therapy.
Haciislamoglu E; Cinar Y; Gurcan F; Canyilmaz E; Gungor G; Yoney A
Br J Radiol; 2019 Oct; 92(1102):20190317. PubMed ID: 31295011
[TBL] [Abstract][Full Text] [Related]
9. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors.
Moteabbed M; Yock TI; Paganetti H
Phys Med Biol; 2014 Jun; 59(12):2883-99. PubMed ID: 24828559
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
11. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of 3D conformal, IMRT, and V-MAT techniques for accelerated partial-breast irradiation (APBI).
Qiu JJ; Chang Z; Horton JK; Wu QR; Yoo S; Yin FF
Med Dosim; 2014; 39(2):152-8. PubMed ID: 24480375
[TBL] [Abstract][Full Text] [Related]
14. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
15. Heart dose reduction in breast cancer treatment with simultaneous integrated boost: Comparison of treatment planning and dosimetry for a novel hybrid technique and 3D-CRT.
Jöst V; Kretschmer M; Sabatino M; Würschmidt F; Dahle J; Ueberle F; Lorenzen J
Strahlenther Onkol; 2015 Sep; 191(9):734-41. PubMed ID: 26206476
[TBL] [Abstract][Full Text] [Related]
16. Estimating cancer risks due to whole lungs low dose radiotherapy with different techniques for treating COVID-19 pneumonia.
Banaei A; Hashemi B; Bakhshandeh M
Radiat Oncol; 2022 Jan; 17(1):10. PubMed ID: 35057839
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy and volumetric-modulated arc therapy for adult craniospinal irradiation--a comparison with traditional techniques.
Studenski MT; Shen X; Yu Y; Xiao Y; Shi W; Biswas T; Werner-Wasik M; Harrison AS
Med Dosim; 2013; 38(1):48-54. PubMed ID: 22878118
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy: volumetric modulated arc therapy versus 3D non-coplanar conformal radiotherapy for the treatment of early stage lung cancer.
Herbert C; Kwa W; Nakano S; James K; Moiseenko V; Wu J; Schellenberg D; Liu M
Technol Cancer Res Treat; 2013 Dec; 12(6):511-6. PubMed ID: 23617285
[TBL] [Abstract][Full Text] [Related]
19. A dosimetric comparison of 3D-CRT, IMRT, and static tomotherapy with an SIB for large and small breast volumes.
Michalski A; Atyeo J; Cox J; Rinks M; Morgia M; Lamoury G
Med Dosim; 2014; 39(2):163-8. PubMed ID: 24393498
[TBL] [Abstract][Full Text] [Related]
20. Estimation of radiation-induced secondary cancer risks for early-stage non-small cell lung cancer patients after stereotactic body radiation therapy.
Han C; Schultheiss TE; Wong JYC
Pract Radiat Oncol; 2017; 7(3):e185-e194. PubMed ID: 28089479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]